{
    "2021-11-15": [
        [
            {
                "time": "",
                "original_text": "国谈价格好于市场预期，有利于创新药板块估值修复！【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "国谈价格",
                        "市场预期",
                        "创新药",
                        "估值修复"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：2021医保谈判落幕 本周医药板块上涨0.82% 建议关注政策受益的原料药板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医保谈判",
                        "医药板块",
                        "原料药",
                        "政策受益"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "原料药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}